Pharmazeutische Zusammensetzung enthaltend sFcRgamma IIb oder sFcRgamma III

摘要

The invention relates to pharmaceutical compositions containing one of the receptors FcyR llb or FcyR III in a recombinant-produced, soluble form, and to the use of the same for the treatment of diseases or conditions which are caused by exuberant immunoreactions and the pathologically increased formation of antibodies, especially auto-antibodies. Said pharmaceutical compositions are especially useful in the fields of multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis.